Clinical trial · Observational
Visceral Adiposity Index Differences Between Subtypes of Polycystic Ovary Syndrome
Visceral Adiposity Index Levels in Polycystic Ovary Syndrome Subtypes
NCT06358300CI-TRIAL-00075907completedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
We aimed to investigate visceral adiposity index (VAI) in patients with different phenotype of policystic ovary syndrome (PCOS) and to compare healthy controls.
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Polycystic Ovary Syndrome | — | UNRESOLVED | — |
| Visceral Adiposity Index | — | UNRESOLVED | — |
Interventions
Interventions (0)
Data not yet available
No intervention recorded.
Design
Arms and outcomes
Arms (5)
- label
- Controls
- description
- Healthy controls between aged 18-35 years
- label
- PCOS Subtype 1
- description
- Hyperandrogenemia+oligoanovulation+PCO appearance on USG
- label
- PCOS Subtype 2
- description
- Hyperandrogenemia+oligoanovulation
- label
- PCOS Subtype 3
- description
- Hyperandrogenemia+PCO appearance on USG
- label
- PCOS Subtype 4
- description
- Oligoanovulation+PCO appearance on USG
Primary outcomes (1)
Eligibility
Eligibility (as posted)
- Sex
- Female
- Minimum age
- 18 Years
- Maximum age
- 35 Years
Show eligibility criteria text
Inclusion Criteria: 1. Patients who applied for reasons such as hair growth, acne, menstrual irregularity or infertility and were diagnosed with PCOS after examination, biochemical, hormonal and sonographic tests, 2. Female patients between the ages of 18-35, 3. Patients without known cancer, liver or kidney failure, 4. Patients who do not take medications that will affect HDL, TG levels and insulin resistance, 5. Female patients without active infection will be included. - Exclusion Criteria: 1. Female patients under eighteen years of age and \>35 years of age, 2. Patients with known cancer, liver and kidney failure, 3. Patients taking medications that will affect HDL, TG levels and insulin resistance, 4. Patients with active infection will not be included in the study. -
References
Publications (0)
Data not yet available
No reference posted for this study.